- Mirion Technologies to attend US NIC Advanced Reactors Summit XIII & Technology Trailblazers Showcase, alongside Paragon and Certrec, marking the first unified presence for the company.
- Companies to showcase a comprehensive nuclear solutions platform to address licensing, regulatory and radiation safety challenges for the Advanced Reactor community.
- Leadership on site, highlighting unified commitment to a seamless partner experience and support for deploying innovative New Nuclear technologies.
ATLANTA – Mirion Technologies, a leading provider of advanced radiation safety solutions, will participate in the Advanced Reactors Summit XIII & Technology Trailblazers Showcase, hosted by the United States Nuclear Industry Council (US NIC), Feb. 10-12, alongside newly acquired companies Paragon and Certrec. The companies will showcase a comprehensive, complementary suite of offerings, uniquely positioned to support New Nuclear deployment and simplify compliance and safety challenges for the Advanced Reactor community.
“The nuclear energy industry needs proven partners now more than ever,” said Thomas Logan, Mirion Chairman and Chief Executive Officer. “Together, Mirion, Paragon, and Certrec harness decades of expertise delivering the solutions, experience and confidence essential to the future of nuclear energy.”
Paragon Chief Nuclear Officer Tighe Smith will be on site along with other company leadership. Smith will speak on a panel at the Advanced Reactors Supply Chain Workshop on Feb. 10, held in conjunction with the summit.
The Advanced Reactors Summit is dedicated to advanced reactors and brings together technology developers, supply-chain leaders, investors and policymakers to move projects forward.
About Mirion
Mirion is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. Focused on nuclear and safety, the Mirion Technologies group is committed to powering advancements in nuclear energy through proven radiation safety technologies and expertise. Dedicated to driving better patient outcomes, the Mirion Medical group is focused on improving quality in cancer care through its broad range of solutions that enhance the delivery and ensure safety across the medical landscape. Headquartered in Atlanta (GA – USA), Mirion employs approximately 3,200 people and operates in 12 countries. Learn more at mirion.com.
For media inquiries:
Erin Schesny
[email protected]
For investor inquiries:
Eric Linn
[email protected]
